Speakers

Nathan Bush

Partner, Head of Investigations, Asia, Head of Antitrust & Competition, Asia at DLA Piper

Irina Dragulev

Assistant General Counsel, M&A Function Lead/Training & Communications Function Lead, Compliance Division at Pfizer Inc.

Kevin Espinoza

SVP, Corporate Compliance & Privacy Officer at BTG International Inc.

David Fuhr

Trial Attorney, Fraud Section (Criminal Division) at U.S. Department of Justice

Thomas Glavin

Chief Compliance Officer at Olympus Corporation of the Americas

John F. Kuckelman

Head of Legal, Asia Pacific, Middle East and Africa at Novartis Pharmaceuticals

Gregory Paw

Partner at Freeh, Sporkin & Sullivan
(former Director of the New Jersey Division of Criminal Justice and Deputy United States Attorney for the Eastern District of Pennsylvania)

David Ralston

Senior Associate General Counsel at Gilead Sciences

Sue Seferian

Health Care Compliance Officer at Johnson & Johnson

Mary Shirley

Senior Director, Ethics & Compliance, Compliance Operations at Fresenius Medical Care North America

Alixandra E. Smith

Deputy Chief, Business and Securities Fraud Section at U.S. Attorney’s Office | Eastern District of New York

Nancy S. Travis

Vice President, International Compliance & Governance at Advanced Medical Technology Association (AdvaMed)

Andrey Valovoy

General Counsel Russia, CIS, Central and Eastern Europe at Eli Lilly and Company

R. David Walk Jr.

Assistant U.S. Attorney, Health Care and Government Fraud Unit at United States Attorney’s Office District of New Jersey

Mark J. Wanda

Executive Director, Head of Anti-Bribery/Anti-Corruption Compliance at Astellas US LLC